3-D MATRIX MEDICAL TECHNOLOGY
Live / Registered — Registered (as of 20 Sept 2022)
What this means for you
Registered since 20 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90515863
- Registration number
- 6854219
- Mark type
- Stylized text
- Filed
- 06 Feb 2021
- Registered
- 20 Sept 2022
- Attorney of record
- CONSTANTINE LINNIK
Goods and services
- Class 005 — Pharmaceuticals: Synthetic peptide hydrogels for medical purposes, namely, as an absorbable bulking agent, hemostatic agent, wound healing agent, agent preventing adhesion and scar tissue formation, and for tissue protection in general, for use in surgical procedures, including endoscopic surgeries, for the treatment of disorders and conditions in ear, nose and throat, gastrointestinal tract, as an embolic agent in treatment of cancer, and agent for uplifting or separating tissues during surgery; syringes pre-filled with synthetic peptide hydrogel solution for aforementioned uses
- Class 044 — Medical, beauty and agricultural services: Providing medical information relating to medical products, namely, about self-assembling peptide hydrogels and their medical applications via a website
Owner
- 3-D Matrix, Ltd., Cambridge, MA, JP
- 3-D Matrix, Ltd., Cambridge, MA, JP
Prosecution history
- 20 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Sept 2022 — REGISTERED-SUPPLEMENTAL REGISTER
- 17 Aug 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 10 Aug 2022 — EXPARTE APPEAL TERMINATED
- 10 Aug 2022 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 10 Aug 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Aug 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Aug 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Aug 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Aug 2022 — ASSIGNED TO LIE
- 19 Jul 2022 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 18 Jul 2022 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 18 Jul 2022 — EX PARTE APPEAL-INSTITUTED
- 18 Jul 2022 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 18 Jul 2022 — EXPARTE APPEAL RECEIVED AT TTAB